AngioDynamics Inc

Find Ratings Reports
ANGO : NASDAQ : Health Care
$16.62 up 0.13 | 0.79%
Today's Range: 16.38 - 16.93
Avg. Daily Volume: 148,700
07/26/16 - 3:59 PM ET

Financial Analysis


ANGIODYNAMICS INC's gross profit margin for the fourth quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. ANGIODYNAMICS INC has average liquidity. Currently, the Quick Ratio is 1.29 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 6.97% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY15 Q4 FY14
Net Sales ($mil)93.3790.9
EBITDA ($mil)8.6612.14
EBIT ($mil)1.684.42
Net Income ($mil)-43.96-0.81


Balance Sheet Q4 FY15 Q4 FY14
Cash & Equiv. ($mil)33.9920.08
Total Assets ($mil)728.06773.62
Total Debt ($mil)121.41137.66
Equity ($mil)507.03545.02


Profitability Q4 FY15 Q4 FY14
Gross Profit Margin46.852.04
EBITDA Margin9.2713.35
Operating Margin1.84.87
Sales Turnover0.490.46
Return on Assets-6.1-0.42
Return on Equity-8.76-0.59
Debt Q4 FY15 Q4 FY14
Current Ratio2.182.55
Debt/Capital0.190.2
Interest Expense0.00.75
Interest Coverage0.05.93


Share Data Q4 FY15 Q4 FY14
Shares outstanding (mil)36.2335.9
Div / share0.00.0
EPS-1.21-0.02
Book value / share14.015.18
Institutional Own % n/a n/a
Avg Daily Volume147512.0101352.0

Valuation


HOLD. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.19 indicates a significant discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 4.84. The price-to-sales ratio is below the S&P 500 average and is well below the industry average, indicating a discount. After reviewing these and other key valuation criteria, ANGIODYNAMICS INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ANGO NM Peers 62.82   ANGO 13.38 Peers 33.31

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

ANGO's P/E is negative making this valuation measure meaningless.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ANGO is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ANGO 23.52 Peers 29.14   ANGO NA Peers 1.03

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

ANGO is trading at a valuation on par with its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ANGO 1.19 Peers 4.84   ANGO -1255.55 Peers 159.18

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ANGO is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ANGO is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ANGO 1.71 Peers 4.71   ANGO -0.98 Peers 20.16

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ANGO is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ANGO significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades